(3beta,20beta)-3-(3-Carboxy-1-oxopropoxy)-11-oxoolean-12-en-29-oic acid

CAS: 5697-56-3

Ref. 3D-FC140637

Información del producto

• Nombre: (3beta,20beta)-3-(3-Carboxy-1-oxopropoxy)-11-oxoolean-12-en-29-oic acid
• Sinónimos: (3Beta)-3-[(3-Carboxypropanoyl)Oxy]-11-Oxoolean-12-En-30-Oic Acid, (3beta)-3-[(3-Carboxypropanoyl)oxy]-11-oxoolean-12-en-30-oic acid Carbenoxolone, (3β,20β)-3-(3-Carboxy-1-oxopropoxy)-11-oxoolean-12-en-29-oic acid, 3-(3-Carboxy-1-oxopropoxy)-11-oxo-olean-12-en-29-oic acid, 3-O-(β-Carboxypropionyl)-11-oxo-18β-olean-12-en-30-oic acid, 3β-Hydroxy-11-oxoolean-12-en-30-oic acid hydrogen succinate, 8Xi,10Xi,17Xi,18Xi)-3-[(3-Carboxypropanoyl)Oxy]-11-Oxoolean-12-En-30-Oic Acid, Biogastrone, Disodium (3Beta,5Xi,9Xi)-3-[(3-Carboxylatopropanoyl)Oxy]-11-Oxoolean-12-En-30-Oate, Glycyrrhetinic Acid Hydrogen Succinate, Glycyrrhetinic acid succinate, Olean-12-en-29-oic acid, 3-(3-carboxy-1-oxopropoxy)-11-oxo-, (3β,20β)-, Olean-12-en-30-oic acid, 3β-hydroxy-11-oxo-, hydrogen succinate, Olean-12-en-30-oic acid, 3β-hydroxy-11-oxo-, succinate
• CAS: 5697-56-3

Descripción

1-Carboxy-2-[(2S,3R,4S)-1-carboxy-3-hydroxypropyl]-sn-glycero 3-phosphoethanolamine is a vaccine that is used to treat bowel disease and autoimmune diseases. It has been shown to induce the production of antibodies against melanoma antigen in mice. This drug also has an effect on metabolic disorders such as diabetes mellitus and obesity. 1-Carboxy-2-[(2S,3R,4S)-1-carboxy-3-hydroxypropyl]-sn-glycero 3-phosphoethanolamine is an ethylene diamine derivative with a hydroxyl group on the C2 position.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 570.76 g/mol
• Fórmula: C₃₄H₅₀O₇
• Pureza: Min. 95%